{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:08:39Z","timestamp":1783796919569,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100010325","name":"Universidad Nacional del Nordeste","doi-asserted-by":"publisher","award":["PI:21V001"],"award-info":[{"award-number":["PI:21V001"]}],"id":[{"id":"10.13039\/501100010325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2017-0038"],"award-info":[{"award-number":["PICT-2017-0038"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The WHO states that antivenom is the only safe and effective treatment to neutralize snake venom. Snakebite antivenom typically involves horse hyperimmunization with crude venom and Freund's adjuvant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In the current work, we analyzed the ascorbyl palmitate liquid crystal structure with snake protein or PLA2, the carrier charge capacity, and we evaluated the immune response induced by the enzyme P9a(Cdt-PLA2) formulated in a nanostructure using CpG-ODN, determining the titer of IgG antibodies. BALB\/c mice were subcutaneously immunized on days 0, 15 and 30 with P9a(Cdt-PLA2)\/CpG-ODN\/Coa-ASC16 or P9a(Cdt-PLA2)\/Freund's adjuvant (complete first and incomplete-booster). On day 48 the mice were sacrificed. The neutralization ability of antibodies from animals immunized with P9a(Cdt-PLA2)\/CpG-ODN\/Coa-ASC16 or P9a(Cdt-PLA2)\/Freund's adjuvant was tested against PLA2 activity and venom lethality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In both groups of immunized mice, the antibody titers in blood samples at the assayed time were high (approximately 1\u00d7105). The antibodies were able to neutralize P9a(Cdt-PLA2) activity in vitro and lethality in vivo. Microscopic analysis showed that P9a(Cdt-PLA2)\/CpG-ODN\/Coa-ASC16 produces minimal damage at injection sites compared with Freund's adjuvant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The Coa-ASC16\/CpG-ODN formulation shows promise as a safe and effective adjuvant against crotalic PLA2, inducing a strong humoral response and reducing local tissue damage compared with Freund's adjuvant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/trstmh\/trae129","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:19:28Z","timestamp":1732979968000},"page":"1070-1083","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of a nanostructured CpG-ODN\/ascorbyl palmitate as a safe and effective adjuvant for anticrotalic PLA2 serum"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-6237","authenticated-orcid":false,"given":"Luciano S","family":"Fusco","sequence":"first","affiliation":[{"name":"Instituto de Qu\u00edmica B\u00e1sica y Aplicada del Nordeste Argentino (IQUIBA-NEA) Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP3400 Corrientes ,","place":["Argentina"]},{"name":"Universidad Nacional del Nordeste Facultad de Ciencias Exactas Naturales y Agrimensura, , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela L","family":"Lopez","sequence":"additional","affiliation":[{"name":"Instituto de Qu\u00edmica B\u00e1sica y Aplicada del Nordeste Argentino (IQUIBA-NEA) Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Maslovski","sequence":"additional","affiliation":[{"name":"Instituto de Qu\u00edmica B\u00e1sica y Aplicada del Nordeste Argentino (IQUIBA-NEA) Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Brignone","sequence":"additional","affiliation":[{"name":"UNITEFA (CONICET) Universidad Nacional de C\u00f3rdoba, Facultad de Ciencias Qu\u00edmicas, Departamento de Ciencias Farmac\u00e9uticas, , CP5000 C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G","family":"Chaves","sequence":"additional","affiliation":[{"name":"Universidad Nacional del Nordeste Facultad de Ciencias Exactas Naturales y Agrimensura, , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"Calvete","sequence":"additional","affiliation":[{"name":"Jaime Roig 11 Instituto de Biomedicina de Valencia, CSIC, , 46010 Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanet G","family":"Franco","sequence":"additional","affiliation":[{"name":"Universidad Nacional del Nordeste Facultad de Ciencias Exactas Naturales y Agrimensura, , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Universidad Nacional del Nordeste Facultad de Ciencias Veterinarias, , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Van de Velde","sequence":"additional","affiliation":[{"name":"Instituto de Qu\u00edmica B\u00e1sica y Aplicada del Nordeste Argentino (IQUIBA-NEA) Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Marin","sequence":"additional","affiliation":[{"name":"Universidad Nacional de C\u00f3rdoba , Facultad de Ciencias Qu\u00edmicas, Departamento de Bioqu\u00edmica Cl\u00ednica, CP5000 C\u00f3rdoba ,","place":["Argentina"]},{"name":"Centro de Investigaciones en Bioqu\u00edmica Cl\u00ednica e Inmunolog\u00eda (CIBICI) Consejo Nacional de CP5000Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP5000 C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Palma","sequence":"additional","affiliation":[{"name":"UNITEFA (CONICET) Universidad Nacional de C\u00f3rdoba, Facultad de Ciencias Qu\u00edmicas, Departamento de Ciencias Farmac\u00e9uticas, , CP5000 C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belkys","family":"Maletto","sequence":"additional","affiliation":[{"name":"Universidad Nacional de C\u00f3rdoba , Facultad de Ciencias Qu\u00edmicas, Departamento de Bioqu\u00edmica Cl\u00ednica, CP5000 C\u00f3rdoba ,","place":["Argentina"]},{"name":"Centro de Investigaciones en Bioqu\u00edmica Cl\u00ednica e Inmunolog\u00eda (CIBICI) Consejo Nacional de CP5000Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP5000 C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Moron","sequence":"additional","affiliation":[{"name":"Universidad Nacional de C\u00f3rdoba , Facultad de Ciencias Qu\u00edmicas, Departamento de Bioqu\u00edmica Cl\u00ednica, CP5000 C\u00f3rdoba ,","place":["Argentina"]},{"name":"Centro de Investigaciones en Bioqu\u00edmica Cl\u00ednica e Inmunolog\u00eda (CIBICI) Consejo Nacional de CP5000Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP5000 C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C","family":"Leiva","sequence":"additional","affiliation":[{"name":"Instituto de Qu\u00edmica B\u00e1sica y Aplicada del Nordeste Argentino (IQUIBA-NEA) Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), , CP3400 Corrientes ,","place":["Argentina"]},{"name":"Universidad Nacional del Nordeste Facultad de Ciencias Exactas Naturales y Agrimensura, , CP3400 Corrientes ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"2025092202571822100_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2018.06.084","article-title":"Current technology for the industrial manufacture of snake antivenoms","volume":"151","author":"Le\u00f3n","year":"2018","journal-title":"Toxicon"},{"key":"2025092202571822100_bib2","doi-asserted-by":"crossref","first-page":"114135","DOI":"10.1016\/j.bcp.2020.114135","article-title":"Snake antivenom: challenges and alternate approaches","volume":"181","author":"Alangode","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2025092202571822100_bib3","volume-title":"WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins","author":"World Health Organization","year":"2010"},{"issue":"28","key":"2025092202571822100_bib4","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2174\/138161207782023784","article-title":"Trends in snakebite envenomation therapy: scientific, technological and public health considerations","volume":"13","author":"Gutierrez","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"7","key":"2025092202571822100_bib5","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1016\/S2214-109X(19)30225-6","article-title":"WHO's Snakebite envenoming strategy for prevention and control","volume":"7","author":"Minghui","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025092202571822100_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ijbiomac.2018.09.203","article-title":"A biotechnological approach to immunotherapy: antivenom against Crotalus durissus cascavella snake venom produced from biodegradable nanoparticles","volume":"120","author":"Gl\u00e1ucia-Silva","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"2025092202571822100_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","article-title":"Venoms, antivenoms and immunotherapy","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"},{"issue":"3","key":"2025092202571822100_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.1711640313","article-title":"Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates","volume":"164","author":"Wiedemann","year":"1991","journal-title":"J Pathol"},{"issue":"3","key":"2025092202571822100_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apm.1965.63.3.340","article-title":"Granulomatous lesions in mice produced by Freund's adjuvant: morphogenesis and phasic development","volume":"63","author":"Wanstrup","year":"1965","journal-title":"Acta Pathologica Microbiologica Scandinavica"},{"issue":"3","key":"2025092202571822100_bib10","first-page":"559","article-title":"Ultrastructural changes in the alveolar epithelium in response to Freund's adjuvant","volume":"64","author":"Faulkner","year":"1971","journal-title":"Am J Pathol"},{"issue":"47","key":"2025092202571822100_bib11","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"2025092202571822100_bib12","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.biomaterials.2013.12.002","article-title":"Adjuvant activity of CpG-ODN formulated as a liquid crystal","volume":"35","author":"Vallecillo","year":"2014","journal-title":"Biomaterials"},{"key":"2025092202571822100_bib13","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3389\/fimmu.2018.02319","article-title":"Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen","volume":"9","author":"Chiodetti","year":"2018","journal-title":"Front Immunol"},{"key":"2025092202571822100_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2015.07.008","article-title":"A liquid crystal of ascorbyl palmitate, used as vaccine platform, provides sustained release of antigen and has intrinsic pro-inflammatory and adjuvant activities which are dependent on MyD88 adaptor protein","volume":"214","author":"Vallecillo","year":"2015","journal-title":"J Controlled Release"},{"key":"2025092202571822100_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.rvsc.2021.02.011","article-title":"Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31\/CpG-ODN\/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in balb\/c mice","volume":"135","author":"Moran","year":"2021","journal-title":"Res Vet Sci"},{"key":"2025092202571822100_bib16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3389\/fimmu.2020.02087","article-title":"A vaccine based on Kunitz-Type molecule confers protection against Fasciola hepatica challenge by inducing IFN-\u03b3 and antibody immune responses through IL-17A production","volume":"11","author":"Silvane","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"2025092202571822100_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update","volume":"20","author":"Lee","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"2025092202571822100_bib18","article-title":"Vaccine tracker and landscape. 19AD","author":"COVID WHO"},{"issue":"1","key":"2025092202571822100_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2015.06.528","article-title":"P9a(Cdt-PLA2) from Crotalus durissus terrificus as good immunogen to be employed in the production of crotalic anti-PLA2 IgG","volume":"238","author":"Fusco","year":"2015","journal-title":"Toxicol Lett"},{"key":"2025092202571822100_bib20","article-title":"Fast venomic analysis of Crotalus durissus terrificus from northeastern Argentina","volume":"7","author":"Fusco","year":"2020","journal-title":"Toxicon: X"},{"key":"2025092202571822100_bib21","article-title":"CpG-ODN formulated with a nanostructure as adjuvant for anticrotalic serum production","volume":"215","author":"Fusco","year":"2022","journal-title":"Studies in mice Toxicon"},{"issue":"6","key":"2025092202571822100_bib22","first-page":"e45","article-title":"He F. Bradford protein assay","volume":"1","year":"2011;","journal-title":"Bio-protocol"},{"issue":"5","key":"2025092202571822100_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/03639040600975238","article-title":"Influence of surfactant on the thermal behavior of marigold oil emulsions with liquid crystal phases","volume":"33","author":"dos Santos","year":"2007","journal-title":"Drug Dev Ind Pharm"},{"key":"2025092202571822100_bib24","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.2147\/IJN.S110406","article-title":"Cubosome nanoparticles potentiate immune properties of immunostimulants","volume":"11","author":"Liu","year":"2016","journal-title":"Int J Nanomed"},{"key":"2025092202571822100_bib25","doi-asserted-by":"crossref","first-page":"114465","DOI":"10.1016\/j.lwt.2023.114465","article-title":"Effects of fibre addition and processing on the stability, rheology and in vitro gastric digestion of whey protein-xanthan gum stabilised emulsions with high oil phase","volume":"178","author":"Kasprzak","year":"2023","journal-title":"LWT"},{"key":"2025092202571822100_bib26","doi-asserted-by":"crossref","first-page":"121311","DOI":"10.1016\/j.ijpharm.2021.121311","article-title":"Nanocrystal-based 3D-printed tablets: semi-solid extrusion using melting solidification printing process (MESO-PP) for oral administration of poorly soluble drugs","volume":"611","author":"Lopez-Vidal","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"2025092202571822100_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biologicals.2014.09.001","article-title":"New immunization protocol to produce crotalic antivenom combining Crotalus durissus terrificus venom and its PLA2","volume":"43","author":"Fusco","year":"2015","journal-title":"Biologicals"},{"issue":"1","key":"2025092202571822100_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J Immunol Methods"},{"issue":"4","key":"2025092202571822100_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0041-0101(88)90010-4","article-title":"An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica","volume":"26","author":"Guti\u00e9rrez","year":"1988","journal-title":"Toxicon"},{"issue":"5","key":"2025092202571822100_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/toxins9050163","article-title":"Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the-art and challenges ahead","volume":"9","author":"Guti\u00e9rrez","year":"2017","journal-title":"Toxins"},{"issue":"1","key":"2025092202571822100_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins8010009","article-title":"Snake venomics and antivenomics of bothrops diporus, a medically important pitviper in northeastern Argentina","volume":"8","author":"Gay","year":"2015","journal-title":"Toxins"},{"issue":"6","key":"2025092202571822100_bib32","first-page":"512","article-title":"Rabbit IgG antibodies against phospholipase A2 from Crotalus durissus terrificus neutralize the lethal activity of the venom","volume":"66","author":"Rodriguez","year":"2006","journal-title":"Medicina"},{"issue":"3","key":"2025092202571822100_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13312-021-2158-x","article-title":"Evolution bites\u2014Timeworn inefficacious snakebite therapy in the era of recombinant vaccines","volume":"58","author":"Kaur","year":"2021","journal-title":"Indian Pediatr"},{"issue":"3","key":"2025092202571822100_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biologicals.2011.02.005","article-title":"Antivenoms for the treatment of snakebite envenomings: the road ahead","volume":"39","author":"Guti\u00e9rrez","year":"2011","journal-title":"Biologicals"},{"key":"2025092202571822100_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-642-66913-2_9","article-title":"Metal and nonprotein constituents in snake venoms","volume":"52","author":"Bieber","year":"1979","journal-title":"Snake Venoms"},{"issue":"1-2","key":"2025092202571822100_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.09.014","article-title":"Nanostructures from alkyl vitamin C derivatives (ASCn): properties and potential platform for drug delivery","volume":"345","author":"Palma","year":"2007","journal-title":"Int J Pharm"},{"issue":"4","key":"2025092202571822100_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11743-016-1816-9","article-title":"Phase behavior of ascorbyl palmitate coagels loaded with oligonucleotides as a new carrier for vaccine adjuvants","volume":"19","author":"Ullio Gamboa","year":"2016","journal-title":"J Surfactants Deterg"},{"issue":"1-3","key":"2025092202571822100_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.colsurfa.2010.11.083","article-title":"The ascorbyl palmitate-water system: phase diagram and state of water","volume":"375","author":"Benedini","year":"2011","journal-title":"Colloids Surf A"},{"key":"2025092202571822100_bib39","first-page":"109973","article-title":"Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom","volume":"284","author":"Maslovski","year":"2024","journal-title":"Comp Biochem Physiol C: Toxicol Pharmacol"},{"issue":"1-2","key":"2025092202571822100_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0928-0987(02)00054-4","article-title":"Evaluation of the surfactant properties of ascorbyl palmitate sodium salt","volume":"16","author":"Palma","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"2025092202571822100_bib41","article-title":"Preparation and characterization of highly water soluble curcumin\u2013dextrose cocrystal","volume-title":"VER WP","author":"Nugroho","year":"2018"},{"issue":"32","key":"2025092202571822100_bib42","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1002\/slct.202002800","article-title":"Thermal behavior of anhydrous ascorbic acid 6-palmitate with trace of decomposition","volume":"5","author":"Ogawa","year":"2020","journal-title":"ChemistrySelect"},{"issue":"4","key":"2025092202571822100_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10238-007-0148-6","article-title":"Subcutaneous inflammation (panniculitis) in tibio-tarsal joint of rats inoculated with complete Freund's adjuvant","volume":"7","author":"Oliveira","year":"2007","journal-title":"Clin Exp Med"},{"key":"2025092202571822100_bib44","article-title":"A CFA-induced model of inflammatory skin disease in miniature swine","volume":"2018","author":"Navarro-Alvarez","year":"2018","journal-title":"Int J Inflamm"},{"issue":"4","key":"2025092202571822100_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/toxins14040235","article-title":"Immunorecognition and neutralization of Crotalus durissus cumanensis venom by a commercial antivenom produced in Colombia","volume":"14","author":"Acosta-Pe\u00f1a","year":"2022","journal-title":"Toxins"},{"issue":"3","key":"2025092202571822100_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1590\/S1678-91992009000300008","article-title":"IgG antibodies against phospholipase A2 from Crotalus durissus terrificus: cross-reaction with venoms from Bothrops species from Argentina","volume":"15","author":"Rodr\u00edguez","year":"2009","journal-title":"J Venom Anim Toxins Trop Dis"},{"issue":"5","key":"2025092202571822100_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"issue":"2","key":"2025092202571822100_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0041-0101(88)90173-0","article-title":"Phospholipase A2 injection in mice induces immunity against the lethal effects of Crotalus durissus terrificus venom","volume":"26","author":"Dos Santos","year":"1988","journal-title":"Toxicon"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/9\/1070\/61270404\/trae129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/9\/1070\/61270404\/trae129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:57:34Z","timestamp":1758524254000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/119\/9\/1070\/7931942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,1,3]]},"published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trae129","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,1,3]]}}}